A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.

The UK is regaining its position as a global hub for industry clinical trials, according to the ABPI, but challenges remain in the space.

A trial has shown that belantamab mafodotin can reduce the risk of death by 42% in patients with relapsed or refractory multiple myeloma.

Amgen is investing $1bn to build a second drug substance manufacturing facility in Holly Springs, North Carolina – increasing the company’s total planned investment in the region to more than $1.5bn.

In a victory for people with sickle cell disease, the US government has announced a major step towards improving access to treatment.

Catch up on all the biggest pharma news to hit the industry last month, with stories spanning the US election, new breakthroughs and more.